Pfizer broke ground for its new biologics clinical manufacturing facility in Andover, MA, and will invest more than $200 million to enable the production of complex biologics and vaccines. The new five-story building is expected to be operational by January 2019, and will add approximately 75 new jobs.   The Andover campus currently includes seven buildings, which house laboratories, clinical and commercial manufacturing suites, and support areas. It also includes a multiproduct manufacturing...